Año: 2018
Journal Impact Factor (JIF): 21.4640
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
CELL & TISSUE ENGINEERING | SCIE | 1/26 | Q1 | T1 | D1 |
CELL BIOLOGY | SCIE | 6/193 | Q1 | T1 | D1 |
Año: 2018
Journal Citation Indicator (JCI): 4,490
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
CELL & TISSUE ENGINEERING | 1/31 | Q1 | T1 | D1 | 98,39 |
CELL BIOLOGY | 7/200 | Q1 | T1 | D1 | 96,75 |
Año:
2018
CiteScore:
36,400
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Cell Biology | 3/270 | Q1 | T1 | D1 |
Genetics | 3/321 | Q1 | T1 | D1 |
Molecular Medicine | 1/167 | Q1 | T1 | D1 |
SJR año:
2018
Factor de Impacto:
11,434
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Cell Biology | 7/303 | Q1 | T1 | D1 |
Genetics | 3/356 | Q1 | T1 | D1 |
Molecular Medicine | 2/179 | Q1 | T1 | D1 |
Agencia | Código de Proyecto |
---|---|
Azrieli Foundation | 2655/16 |
Brazil/Weizmann Institute of Science, Israel | 2015/50166-8 |
CAMS Fundamental Research Funds for Central Research Institutes | 2016GH3100001 |
CAMS Initiative for Innovative Medicine | 2016-I2M-1-017 |
Canadian Institutes of Health Research (CIHR) | - |
Dr. Beth Rom-Rymer Stem Cell Research Fund | - |
Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine | - |
Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) | 15/50166-8 |
International Development Research Centre (IDRC) | - |
ISF-NSFC joint research program | 2474/16 |
Israel Science Foundation (ISF) | - |
Mashkin Family Foundation | - |
Pertman Fund for Stem Cell Research | - |
Sao Paulo Research Foundation (FAPESP) | - |
# | Autor | Afiliación |
---|---|---|
1 | Golan, K | Weizmann Institute of Science (Israel) |
2 | Kumari, A | Weizmann Institute of Science (Israel) |
3 | Kollet, O | Weizmann Institute of Science (Israel) |
4 | Khatib-Massalha, E | Weizmann Institute of Science (Israel) |
5 | Subramaniam, MD | Weizmann Institute of Science (Israel) |
6 | Ferreira, ZS | Universidade de Sao Paulo (Brazil) |
7 | Avemaria, F | Weizmann Institute of Science (Israel) |
8 | Rzeszotek, S | Pomeranian Medical University (Poland) |
9 | García-García, A | University of Cambridge (England) |
10 | Xie, S | Princess Margaret Cancer Centre (Canada) |
11 | Flores-Figueroa, E | Instituto Mexicano del Seguro Social; Princess Margaret Cancer Centre (Mexico) |
12 | Gur-Cohen, S | Weizmann Institute of Science (Israel) |
13 | Itkin, T | Weizmann Institute of Science (Israel) |
14 | Ludin-Tal, A | Weizmann Institute of Science (Israel) |
15 | Massalha, H | Weizmann Institute of Science (Israel) |
16 | Bernshtein, B | Weizmann Institute of Science (Israel) |
17 | Ciechanowicz, AK | University of Warsaw (Poland) |
18 | Brandis, A | Weizmann Institute of Science (Israel) |
19 | Mehlman, T | Weizmann Institute of Science (Israel) |
20 | Bhattacharya, S | Weizmann Institute of Science (Israel) |
21 | Bertagna, M | Weizmann Institute of Science (Israel) |
22 | Cheng, H | Institute of Hematology & Blood Diseases Hospital - CAMS; Peking Union Medical College (Peoples R China) |
23 | Petrovich-Kopitman, E | Weizmann Institute of Science (Israel) |
24 | Janus, T | Pomeranian Medical University (Poland) |
25 | Kaushansky, N | Weizmann Institute of Science (Israel) |
26 | Cheng, T | Institute of Hematology & Blood Diseases Hospital - CAMS; Peking Union Medical College (Peoples R China) |
27 | Sagi, I | Weizmann Institute of Science (Israel) |
28 | Ratajczak, MZ | University of Louisville (USA) |
29 | Méndez-Ferrer, S | University of Cambridge (England) |
30 | Dick, JE | Princess Margaret Cancer Centre (Canada) |
31 | Markus, RP | Universidade de Sao Paulo (Brazil) |
32 | Weizmann Institute of Science (Israel) |